Table 4.
Cohort | Dose | ADA-positive/Total Patients |
---|---|---|
1 | IV 0.1 μg/kg | 0/1 |
2 | IV 0.3 μg/kg | 0/3 |
3 | IV 1 μg/kg | 0/3 |
4 | IV 3 μg/kg | 2/5 |
5 | SC 3 μg/kg | 2/3 |
6 | SC 10 μg/kg | 4/6 |
7 | SC 30 μg/kg | 3/4 |
8 | SC 10 then 30 μg/kg | 3/5 |
9 | SC 10 then 55 μg/kg | 2/5 |
10 | SC 5 and 20, then 60 μg/kg | 3/4 |
ADA, anti-drug-antibodies; IV, intravenous; SC, subcutaneous.